Week26, 2022
1. Nationwide, 1.4% of clinical lab specimens tested positive for influenza, with 97.3% being Influenza A and 2.7% Influenza B.
2. Public health labs reported 44 positive specimens, 97.7% typed as Influenza A (all H3N2) and 2.3% as Influenza B.
3. 1.7% of outpatient visits were due to influenza-like illness (ILI), with the highest percentage (7.4%) among children aged 0-4 years.
4. Influenza hospitalization surveillance recorded 964 new hospitalizations for lab-confirmed influenza for week 26.
5. Influenza-associated pediatric mortality included one newly reported death, totaling 32 deaths for the 2021-2022 season.
6. Pneumonia, influenza, and COVID-19 (PIC) accounted for 8.8% of deaths, exceeding the epidemic threshold, with most due to COVID-19 and 12 linked to influenza.
7. Vaccination trends were not highlighted in this report, and influenza-associated data remained steady compared to prior weeks.
8. Long-term care facility surveillance reported influenza activity in 0.2% (35 of 14,559 facilities) during the week.
9. Minimal influenza activity levels were reported in 47 jurisdictions, with no areas experiencing very high activity.
10. Future influenza trends remain uncertain, with multiple respiratory viruses co-circulating and healthcare behaviors continuing to evolve post-COVID-19 pandemic.